251 related articles for article (PubMed ID: 8893989)
1. Vaccines for bluetongue.
Murray PK; Eaton BT
Aust Vet J; 1996 Jun; 73(6):207-10. PubMed ID: 8893989
[TBL] [Abstract][Full Text] [Related]
2. Vaccines against bluetongue in Europe.
Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Comtet L; Lövgren Bengtsson K; Pringle J; Zientara S; Valarcher JF
Clin Vaccine Immunol; 2013 Aug; 20(8):1115-22. PubMed ID: 23720365
[TBL] [Abstract][Full Text] [Related]
5. Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep.
Celma CC; Boyce M; van Rijn PA; Eschbaumer M; Wernike K; Hoffmann B; Beer M; Haegeman A; De Clercq K; Roy P
J Virol; 2013 Sep; 87(17):9856-64. PubMed ID: 23824810
[TBL] [Abstract][Full Text] [Related]
6. Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8.
van Gennip RG; van de Water SG; Maris-Veldhuis M; van Rijn PA
PLoS One; 2012; 7(9):e44619. PubMed ID: 23049753
[TBL] [Abstract][Full Text] [Related]
7. Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.
Celma CC; Stewart M; Wernike K; Eschbaumer M; Gonzalez-Molleda L; Breard E; Schulz C; Hoffmann B; Haegeman A; De Clercq K; Zientara S; van Rijn PA; Beer M; Roy P
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795442
[TBL] [Abstract][Full Text] [Related]
8. Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection.
Kochinger S; Renevey N; Hofmann MA; Zimmer G
Vet Res; 2014 Jun; 45(1):64. PubMed ID: 24928313
[TBL] [Abstract][Full Text] [Related]
9. A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep.
Hunter P; Modumo J
Onderstepoort J Vet Res; 2001 Dec; 68(4):331-3. PubMed ID: 12026066
[TBL] [Abstract][Full Text] [Related]
10. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
Feenstra F; Maris-Veldhuis M; Daus FJ; Tacken MG; Moormann RJ; van Gennip RG; van Rijn PA
Vaccine; 2014 Dec; 32(52):7108-14. PubMed ID: 25454873
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for Prevention of Bluetongue and Epizootic Hemorrhagic Disease in Livestock: A North American Perspective.
McVey DS; MacLachlan NJ
Vector Borne Zoonotic Dis; 2015 Jun; 15(6):385-96. PubMed ID: 26086559
[TBL] [Abstract][Full Text] [Related]
12. Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep.
Mokoena NB; Moetlhoa B; Rutkowska DA; Mamputha S; Dibakwane VS; Tsekoa TL; O'Kennedy MM
Vaccine; 2019 Sep; 37(41):6068-6075. PubMed ID: 31471154
[TBL] [Abstract][Full Text] [Related]
13. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
Feenstra F; Pap JS; van Rijn PA
Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
[TBL] [Abstract][Full Text] [Related]
14. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
[TBL] [Abstract][Full Text] [Related]
15. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
[TBL] [Abstract][Full Text] [Related]
16. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.
Roy P; Bishop DH; LeBlois H; Erasmus BJ
Vaccine; 1994 Jul; 12(9):805-11. PubMed ID: 7975859
[TBL] [Abstract][Full Text] [Related]
17. Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle.
Hamers C; Galleau S; Chery R; Blanchet M; Besancon L; Cariou C; Werle-Lapostolle B; Hudelet P; Goutebroze S
Vet Rec; 2009 Sep; 165(13):369-73. PubMed ID: 19783850
[TBL] [Abstract][Full Text] [Related]
18. Bluetongue vaccines: the past, present and future.
Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge.
Moreno S; Calvo-Pinilla E; Devignot S; Weber F; Ortego J; Brun A
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008942. PubMed ID: 33275608
[TBL] [Abstract][Full Text] [Related]
20. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]